Amarin | AMRN - Market Capitalization

Stock Price
15.23
Daily Change
-0.11 -0.70%
Monthly
-2.60%
Yearly
83.53%
Q1 Forecast
14.88

Amarin reported $317.6M in Market Capitalization this March of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
AbbVie USD 403.83B 5.2B Dec/2025
Alnylam Pharmaceuticals USD 52.54B 7.24B Dec/2025
Amarin USD 341M 4M Sep/2025
AstraZeneca USD 288.15B 55.08B Dec/2025
BioCryst Pharmaceuticals USD 1.7B 40M Mar/2026
DBV Technologies USD 274M 17M Sep/2025
Esperion Therapeutics USD 475M 410M Mar/2026
GlaxoSmithKline GBP 74.36B 10.31B Dec/2025
Halozyme Therapeutics USD 7.91B 664M Dec/2025
Heron Therapeutics USD 133M 105M Mar/2026
Ionis Pharmaceuticals USD 12.81B 2.39B Dec/2025
Neurocrine Biosciences USD 14.14B 218M Dec/2025
Novartis USD 265.66B 9.48B Sep/2025